Platelet GPIIb/IIIa antagonists: how safe is this antithrombotic approach?
Mousa
S A
SA
De Grado
W F
WF
Reilly
T M
TM
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000077542:Eptifibatide; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors*; D013923:Thromboembolism / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010980:Platelet Membrane Glycoproteins; D000077542:Eptifibatide; D000077284:Abciximab